CASI Pharmaceuticals
CASI
#10191
Rank
NZ$27.54 M
Marketcap
NZ$1.34
Share price
5.68%
Change (1 day)
-68.15%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.64. In 2024 the company made an earnings per share (EPS) of NZ-$4.29 a decrease over its 2023 EPS that were of NZ-$3.38.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.658.44%
2024NZ-$4.2926.73%
2023NZ-$3.38-32.89%
2022NZ-$5.0411.9%
2021NZ-$4.51-38.44%
2020NZ-$7.32-8.96%
2019NZ-$8.0450%
2018NZ-$5.3677.78%
2017NZ-$3.025.88%
2016NZ-$2.85-22.73%
2015NZ-$3.69-76.09%
2014NZ-$15.41318.18%
2013NZ-$3.69-71.79%
2012NZ-$13.0765.96%
2011NZ-$7.87-50%
2010NZ-$15.75-18.97%
2009NZ-$19.43-63.64%
2008NZ-$53.453.57%
2007NZ-$51.60-60.56%
2006NZ-$130.8597.22%
2005NZ-$66.35-2.7%
2004NZ-$68.19-45.59%
2003NZ-$125.32-61.8%
2002NZ-$328.04-25.52%
2001NZ-$440.46-21.38%
2000NZ-$560.2513.86%
1999NZ-$492.07149.53%
1998NZ-$197.1998.15%
1997NZ-$99.5210.2%
1996NZ-$90.30